News
Initiative aims to expand and encourage philanthropy to help patients with retinal diseases afford their medicationsTARRYTOWN, N.Y., June 24, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc.
Stocktwits on MSN4d
Regeneron, Sanofi Say Their Inflammation Drug Approved By FDA For Rare Skin Disease Affecting Elderly, But Retail Stays DullRegeneron Pharmaceuticals, Inc. (REGN) and Sanofi (SNY) on Friday announced that the U.S. Food and Drug Administration (FDA) ...
StockStory.org on MSN2d
The Top 5 Analyst Questions From Regeneron’s Q1 Earnings CallRegeneron’s first quarter was marked by a negative market reaction, as revenue and non-GAAP earnings fell short of Wall ...
Regeneron’s COVID-19 antibody cocktail has been added to the UK’s RECOVERY trial, one of the largest of its kind in the world that is testing several potential coronavirus therapies at the ...
Lynozyfic’s global sales are projected to reach $707 million by 2031.
Anne Wojcicki’s winning bid to reclaim control of 23andMe doesn’t necessarily end the fight over what happens to the DNA of ...
The Food and Drug Administration approved the drug for adult patients with bullous pemphigoid, which mainly affects the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback